VACI

NYSE · N/A

Viking Acquisition Corp - A

Small-Cap Stocks

$10.22

+0.00 (+0.00%)

As of Jul 4, 2:02 AM ET ·

VACI News1 articles

Viking Therapeutics Surges on Obesity Drug Hopes

Viking Therapeutics shares climbed 6% to $34.30 as investors bet on upcoming Phase 3 data for its obesity drug VK2735, expected in Q3 2026.